HRT Financial’s Silo Pharma SILO Stock Holding History

HRT Financial’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-763	Closed	-$10K	–	3304
2024 Q4	$10K	Buy	+763	New	+$11.8K	﹤0.01%	2283

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial's SILO Position: Q1 2025 in Review

HRT Financial sold out of Silo Pharma (SILO) in Q1 2025, closing a stake of 763 shares — an estimated $10K sold.

HRT Financial first reported a position in SILO in Q4 2024 and held it in 1 quarter. The position peaked at $10K in Q4 2024. 13 funds tracked by Wall St. Rank hold SILO as of Q1 2025.

HRT Financial reported no remaining Silo Pharma position as of Q1 2025 after selling out during the quarter.
HRT Financial sold 763 Silo Pharma shares in Q1 2025, an estimated $10K.
HRT Financial first reported a position in Silo Pharma in Q4 2024 and held it in 1 quarter.
HRT Financial's Silo Pharma position peaked at $10K in Q4 2024.
13 funds tracked by Wall St. Rank held Silo Pharma as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.